Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Stockholders Equity of $6.09 billion for fiscal year 2025.
BIOMARIN PHARMACEUTICAL INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.09B | +7.6% |
| 2024 | $5.66B | +14.3% |
| 2023 | $4.95B | +7.6% |
| 2022 | $4.60B | +7.9% |
| 2021 | $4.27B | +4.0% |
| 2020 | $4.10B | +31.3% |
| 2019 | $3.12B | +5.2% |
| 2018 | $2.97B | +5.7% |
| 2017 | $2.81B | +1.5% |
| 2016 | $2.77B | +15.2% |
| 2015 | $2.40B | +57.1% |
| 2014 | $1.53B | +13.9% |
| 2013 | $1.34B | +32.0% |
| 2012 | $1.02B | +31.4% |
| 2011 | $773.05M | +7.8% |
| 2010 | $717.26M | +122.6% |
| 2009 | $322.19M | +16.4% |
| 2008 | $276.68M | +47.4% |
| 2007 | $187.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.06B | +11.9% | +0.5% |
| June 30, 2025 | $6.03B | +14.0% | +4.0% |
| March 31, 2025 | $5.79B | +14.2% | +2.4% |
| December 31, 2024 | $5.66B | +14.3% | +4.5% |
| September 30, 2024 | $5.41B | +10.5% | +2.4% |
| June 30, 2024 | $5.29B | +10.5% | +4.2% |
| March 31, 2024 | $5.07B | +8.9% | +2.5% |
| December 31, 2023 | $4.95B | +7.6% | +1.1% |
- BIOMARIN PHARMACEUTICAL INC showed an increase of +7.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, BIOMARIN PHARMACEUTICAL INC’s stockholders equity has grown by 3142.5% (from $187.73 million to $6.09 billion).
- The most recent figure is from BIOMARIN PHARMACEUTICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: